JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline. Jazz Pharmaceuticals plans to expand indications for two oncology drugs, namely zanidatamab and Zepzelca.

Dec 23, 2024 · Most significant clinical trials of 2024. From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of 2024.

Jan 13, 2025 · Figure 1: Obesity clinical trials and innovator drug obesity trials, 2015-2025. Credit: GlobalData. There are over 300 glucagon-like peptide-1 receptor (GLP-1R) drugs in an active stage of development as the astounding success of Novo Nordisk’s GLP-1R obesity drug, Wegovy, has ignited a surge in ...

4 days ago · Pfizer’s metastatic colorectal cancer (mCRC) combination therapy has met one of the primary endpoints of improving progression-free survival (PFS) in a Phase III trial, further supporting a full approval.. The company’s active-controlled, open-label BREAKWATER trial (NCT05217446) evaluating a combination of Pfizer’s Braftovi (encorafenib), Eli Lilly’s Erbitux (cetuximab) and mFOLFOX6 ...

Nov 1, 2024 · This regulatory uncertainty intersects with ethical concerns over patient safety, data privacy, and equity. “We need to be aligned with the ethics when we’re speaking about technology and innovation,” said Francine Metelo Masega-A-Gulema, regional lead of WEIC DEICE at Pfizer.

Velocity and VCT to address double enrolment challenge in clinical trials. Double enrolment in trials can have severe consequences and can jeopardise subjects' health.

Clinicaltrialsarena.com covers every aspect of the drug development and research process, from conception to pre-FDA approval.. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone – from senior management through to research and QA staff – …

Cumberland Pharmaceuticals reports data from trial of ifetroban for DMD. US-based pharmaceutical company Cumberland Pharmaceuticals has reported positive top-line outcomes from a Phase II trial of ifetroban as a potential…

Sections. Company A-Z; Company Categories; Products & Services; Company Releases; White Papers; Videos; Buyer's Guides; Partner Content; Latest. Bladder cancer: Shaping the future of global clinical trials

Japan accounts for 4.7% share of global clinical trial activity in 2022. Japan has accounted for a 4.7% share of the global clinical trials activity in 2022, registering a decrease when compared…